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The trophoblast, which is derived from
the extraembryonic trophectoderm, is the
first cells differentiated from the pre-
implantation mammalian embryos. In this
regard, two differentiation pathways are
critical for the survival and development
of the embryo in utero. In the first one,
cytotrophoblasts (CTBs) fuse into a layer
of syncytiotrophoblasts that covers the
chorionic villi. These cells are responsi-
ble for hormone production, nutrient and
gas exchanges between the mother and the
developing fetus. In the second one, CTBs
in the anchoring chorionic villi invade
the uterus and its blood vessels estab-
lishing the maternal-fetal interface (Red-
Horse et al., 2004; Roberts and Fisher,
2011). Dysfunction of these differentiation
pathways is associated with a wide range
of human pregnancy complications such
as infertility, preterm birth, pre-eclampsia,
intrauterine growth restriction and aneu-
ploidies (Red-Horse et al., 2004).
To date, most of the insights on pla-
cental trophoblast development have been
gained through transgenic mouse mod-
els and mouse trophoblast stem cells with
placental defects (Kunath et al., 2004).
Despite similarities to human phenotype,
mouse models have several drawbacks and
cannot integrate the specificities of human
placentation. To overcome the unfeasibil-
ity of performing in vivo experimenta-
tion in humans, cell lines derived from
human choriocarcinoma or virally trans-
formed human trophoblast cell lines are
widely used to investigate the mechanisms
involved in trophoblast differentiation
(Hannan et al., 2010). However, general
limitations of using cell lines exist such as
their genetic background and the potential
changes acquired after their transforma-
tion and during their establishment in
culture. Alternatively, primary trophoblast
cultures have been derived from human
placentas at the first trimester or at term
of pregnancy. While these cells might be
an excellent model to study trophoblast
differentiation, they are often difficult to
obtain and do not proliferate in culture. In
addition, these cells are already committed
to the trophoblast lineage and therefore are
not amenable to study early trophoblast
development.
The discovery that human pluripo-
tent stem cells (hPSCs) can be differ-
entiated into trophoblast cells through
bone morphogenetic proteins (BMPs) (Xu
et al., 2002) has opened up a new
field of investigation in human tro-
phoblast developmental biology and dis-
ease (Ezashi et al., 2012; Golos et al., 2013).
Thomson’s group was the first show-
ing trophoblast differentiation of human
embryonic stem cells (hESCs) following
BMP4 treatment (Xu et al., 2002). Then,
the same group has shown that in the
presence of high concentrations of FGF2,
BMP4 treatment results in the differ-
entiation of hESCs into mesendoderm
rather than trophoblast. They demon-
strated in particular that FGF signaling
switches BMP4-induced differentiation of
hESCs into mesendoderm via the main-
tenance of NANOG expression through
MEK/ERK pathway (Yu et al., 2011).
Thereafter, other studies have emphasized
the need of dual inhibition of FGF sig-
naling (with PD173074 or SU5402) and
TGF-β/ACTIVIN/NODAL signaling (with
SB431542 or A83-01) to support tro-
phoblast induction specifically (Sudheer
et al., 2012; Amita et al., 2013). Under
these conditions, BMP4-induced differen-
tiation leads to the emergence of both
chorionic gonadotrophin β-secreting syn-
cytiotrophoblasts with a villous CTB phe-
notype and HLA-G+ trophoblast cells
with invasive properties as the extravil-
lous CTBs (Marchand et al., 2011; Sudheer
et al., 2012; Amita et al., 2013; Li et al.,
2013). Furthermore, by their ability to
recapitulate the early and late steps of
trophoblast development, hESCs should
become valuable tools to study the cellu-
lar and molecular mechanisms involved in
trophoblast cell maintenance, specification
and differentiation.
Since 2007, the generation of human
induced pluripotent stem cells (hiPSCs)
has allowed researchers to study the
development and/or progression of sev-
eral pathologies including neurological
diseases [reviewed in Hibaoui and Feki
(2012)]. It is undoubted that similar
approaches using patient-specific iPSCs
will offer the opportunity to repro-
duce normal and pathological trophoblast
development. Moreover, hiPSCs exhibited
additional advantages compared to hESCs.
First, hiPSCs do not require the use of
human embryos, which makes their use
in basic research less ethically controver-
sial. They are also technically easier to
obtain. Last but not least, they offer the
opportunity to generate iPSC lines spe-
cific for patients with pregnancy com-
plications. Of note, the recent discovery
that iPSCs generated by in vivo repro-
gramming of adult mouse cells efficiently
differentiate into the three germ layers
and extraembryonic tissue (Abad et al.,
2013), may improve our understanding of
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extraembryonic lineage development and
placenta-associated disorders.
In conclusion, while further studies
are needed to improve the efficiency of
hPSC differentiation into trophoblast cells,
we believe that this technology provides
a promising alternative model to study
trophoblast development. In fact, under-
standing and elucidating the mechanisms
regulating human trophoblast develop-
ment using hPSCs is critical not only
in basic research but also in clinical
medicine. It could provide novel insights
into blastocyst formation, implantation
and placentation processes in humans.
Thus, patient-specific hPSCs will also open
up new exciting avenues for the identifi-
cation of genetic and biochemical markers
that could be useful for the prediction and
management of pregnancy complications
such as pre-eclampsia, intrauterine growth
restriction and aneuploidies. The coming
years will tell whether these cells fulfil their
promise.
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